Left Atrial Appendage Closure Devices Market Analysis

Left Atrial Appendage Closure Devices Market Analysis

Left atrial appendage closure devices market is classified as per product into endocardial LAA devices and epicardial LAA devices. The epicardial LAA devices segment is set to exceed USD 725 million by 2032. Epicardial left atrial appendage occlusion reduces the incidences of atrial fibrillation recurrence while improving the electrical and structural remodeling of the LAA. Moreover, these devices need a smaller trans-septal sheath needed for LA access, lowering the chance of an intra-atrial shunt, which is foreseen to propel product demand.
 

Based on procedure, the left atrial appendage closure devices market is segmented into percutaneous and surgical. The percutaneous segment is anticipated to expand at over 12.5% CAGR through 2032. Percutaneous left atrial appendage (LAA) closure is a promising alternative to anticoagulant therapy for those who are diagnosed with atrial fibrillation and are at a high risk of cerebrovascular events. For successful percutaneous LAA closure, market players are designing self-expanding devices. Furthermore, percutaneous minimally invasive surgery is highly preferred as it requires only a minor incision and leaves minimal scars, which is likely to foster segment outlook.
 

Left atrial appendage closure devices market is segmented based on end-use into ambulatory surgical centers, hospitals, and others. Ambulatory surgical centers segment valuation is expected to surpass USD 890 million by 2032. The increased need for minimally invasive surgical methods and the rise in the presence of ambulatory surgical facilities are impelling segment growth. Additionally, ambulatory surgical centers are working on enhancing and accelerating post-surgery recovery, along with offering affordable and high-quality services, which is slated to support industry statistics.

North America left atrial appendage closure devices market accounted for over 46% of the overall industry revenue in 2022 and is projected to observe notable growth through 2032. An upsurge in accidental injuries, a high acceptance rate of advanced upper limb prosthetics, and the expanding elderly population nationwide are responsible for the sizable market share. In addition, several other factors, such as growing consumer awareness pertaining to the advantages of artificial limbs, the presence of major market participants, and the mounting frequency of chronic diseases, are set to further boost regional market progress.